BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 14677669)

  • 1. Escitalopram (Lexapro) for depression.
    Masilamani S; Ruppelt SC
    Am Fam Physician; 2003 Dec; 68(11):2235-6. PubMed ID: 14677669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Escitalopram.
    Aronson S; Delgado P
    Drugs Today (Barc); 2004 Feb; 40(2):121-31. PubMed ID: 15045034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Escitalopram : a review of its use in the management of major depressive and anxiety disorders.
    Waugh J; Goa KL
    CNS Drugs; 2003; 17(5):343-62. PubMed ID: 12665392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost effectiveness of escitalopram versus SNRIs in second-step treatment of major depressive disorder in Sweden.
    Nordström G; Despiegel N; Marteau F; Danchenko N; Maman K
    J Med Econ; 2010; 13(3):516-26. PubMed ID: 20698748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Escitalopram in the treatment of major depressive disorder: clinical efficacy, tolerability and cost-effectiveness vs. venlafaxine extended-release formulation.
    Llorca PM; Fernandez JL
    Int J Clin Pract; 2007 Apr; 61(4):702-10. PubMed ID: 17394446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Higher probability of remission with escitalopram in comparison to citalopram].
    Linné AB; Hallberg I
    Lakartidningen; 2009 Apr 28-May 12; 106(18-19):1292; discussion 1292-3. PubMed ID: 19537504
    [No Abstract]   [Full Text] [Related]  

  • 7. [Escitalopram versus citalopram in true depression. Review of studies do not support clinically relevant differences of the effect].
    Schwan S; Hallberg P
    Lakartidningen; 2009 Mar 18-24; 106(12):858-61. PubMed ID: 19452787
    [No Abstract]   [Full Text] [Related]  

  • 8. Managing depressive and anxiety disorders with escitalopram.
    Thase ME
    Expert Opin Pharmacother; 2006 Mar; 7(4):429-40. PubMed ID: 16503815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.
    Kennedy SH; Andersen HF; Lam RW
    J Psychiatry Neurosci; 2006 Mar; 31(2):122-31. PubMed ID: 16575428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacology review of escitalopram for the treatment of depression.
    Pastoor D; Gobburu J
    Expert Opin Drug Metab Toxicol; 2014 Jan; 10(1):121-8. PubMed ID: 24289655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A new quality of the therapy of anxiety and depression--escitalopram].
    Neznanov NG; Bortsov AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(2):79-84. PubMed ID: 15792148
    [No Abstract]   [Full Text] [Related]  

  • 12. Spotlight on escitalopram in the management of major depressive disorder.
    Murdoch D; Keam SJ
    CNS Drugs; 2006; 20(2):167-70. PubMed ID: 16478291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic impact of therapeutic substitution of a brand selective serotonin reuptake inhibitor with an alternative generic selective serotonin reuptake inhibitor in patients with major depressive disorder.
    Wu EQ; Yu AP; Lauzon V; Ramakrishnan K; Marynchenko M; Ben-Hamadi R; Blum S; Erder MH
    Ann Pharmacother; 2011 Apr; 45(4):441-51. PubMed ID: 21415162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Escitalopram: a review of its use in the management of major depressive disorder.
    Murdoch D; Keam SJ
    Drugs; 2005; 65(16):2379-404. PubMed ID: 16266205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Escitalopram versus serotonin reuptake inhibitors].
    Millet B
    Encephale; 2008 Jun; 34(3):280-3. PubMed ID: 18558150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statement of the AGNP-Work Group "Child and Adolescent Pharmacology" on the decision of the Joint Federal Committee (GBA) of the 17/02/2011 to combine escitalopram with citalopram into a fixed amount group.
    Kölch M
    Pharmacopsychiatry; 2012 May; 45(3):III. PubMed ID: 22592454
    [No Abstract]   [Full Text] [Related]  

  • 17. The influence of baseline severity on efficacy of escitalopram and citalopram in the treatment of major depressive disorder: an extended analysis.
    Lam RW; Andersen HF
    Pharmacopsychiatry; 2006 Sep; 39(5):180-4. PubMed ID: 16944409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Escitalopram.
    Burke WJ
    Expert Opin Investig Drugs; 2002 Oct; 11(10):1477-86. PubMed ID: 12387707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Escitalopram in the treatment of major depressive disorder: a meta-analysis.
    Kennedy SH; Andersen HF; Thase ME
    Curr Med Res Opin; 2009 Jan; 25(1):161-75. PubMed ID: 19210149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between mean platelet volume and major depression.
    Varol E; Akpinar A
    J Clin Psychopharmacol; 2013 Oct; 33(5):723. PubMed ID: 23948792
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.